Last $37.19 USD
Change Today +0.57 / 1.56%
Volume 505.8K
HLS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 6:40 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

healthsouth corp (HLS) Snapshot

Open
$36.52
Previous Close
$36.62
Day High
$38.38
Day Low
$36.44
52 Week High
07/25/14 - $38.38
52 Week Low
02/5/14 - $29.82
Market Cap
3.3B
Average Volume 10 Days
372.0K
EPS TTM
$2.28
Shares Outstanding
88.1M
EX-Date
09/29/14
P/E TM
16.3x
Dividend
$0.84
Dividend Yield
1.94%
Current Stock Chart for HEALTHSOUTH CORP (HLS)

healthsouth corp (HLS) Related Businessweek News

No Related Businessweek News Found

healthsouth corp (HLS) Details

HealthSouth Corporation owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. Its inpatient rehabilitation hospitals offer specialized rehabilitative care services to patients in various disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals, including 72 owned hospitals and 31 jointly owned hospitals in 28 states and Puerto Rico; operated 20 outpatient rehabilitation satellite clinics; and managed 3 inpatient rehabilitation units through management contracts, as well as 25 licensed and hospital-based home health agencies. The company was founded in 1983 and is headquartered in Birmingham, Alabama.

16,609 Employees
Last Reported Date: 04/29/14
Founded in 1983

healthsouth corp (HLS) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $525.0K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $600.0K
Executive Vice President, General Counsel and...
Total Annual Compensation: $527.0K
Chief Human Resources Officer and Executive O...
Total Annual Compensation: $345.0K
Compensation as of Fiscal Year 2013.

healthsouth corp (HLS) Key Developments

HealthSouth Corporation Declares Dividend on Common and Preferred Stock, Payable on October 15, 2014 Respectively

HealthSouth Corporation announced that its board of directors has approved an increase in the company's quarterly dividend of 16.7% and has declared a quarterly cash dividend on its common stock of $0.21 per share and a quarterly cash dividend of $16.25 per share on its 6.5% Series A Convertible Perpetual Preferred Stock, each payable on October 15, 2014, to holders of record on October 1, 2014.

HealthSouth Corporation and Memorial Health Announce Joint Venture to Operate Rehabilitation Hospital in Savannah, Georgia

HealthSouth Corporation and Memorial Health have signed an agreement to form a joint venture to own and operate a 50-bed inpatient physical rehabilitation hospital to be known as the Rehabilitation Hospital of Savannah. Initially, the Rehabilitation Hospital of Savannah will operate in the current location of Memorial Health's 50-bed Rehabilitation Institute on Memorial University Medical Center's campus at 4700 Waters Avenue in Savannah, Georgia and continue to serve patients with needs for intense physical rehabilitation. The joint venture plans to begin building a new, 50-bed replacement inpatient rehabilitation hospital, which is expected to be completed in early 2016 and will provide comprehensive, inpatient physical rehabilitation to patients who have experienced stroke, trauma, brain injury, complex orthopedic conditions as well as other major illnesses or injuries.

HealthSouth Corporation Revised Earnings Guidance for the Year 2014

HealthSouth Corporation has acquired an additional equity interest in Fairlawn Rehabilitation Hospital in Worcester, Massachusetts from its joint venture partner, UMass Memorial Health Care. This transaction increases HealthSouth's ownership interest from 50% to 80% and results in a change in accounting for this hospital from the equity method of accounting to a consolidated entity beginning June 1, 2014. As a result of the consolidation of this hospital and the re-measurement of its previously held equity interest to fair value, the company expects to record a $25 million to $30 million gain during the second quarter of 2014. Had HealthSouth's 50% investment in the Fairlawn hospital been accounted for on a consolidated basis for the full year of 2013, its 2013 Adjusted EBITDA would have been $6.0 million higher. Earlier on April 28, 2014, HealthSouth disclosed it expected to be at the high end of the following guidance ranges: Adjusted EBITDA in the range of $555 million to $565 million and income from continuing operations attributable to HealthSouth per diluted share in the range of $1.86 to $1.91. As a result of this transaction, HealthSouth now expects to exceed the high end of these guidance ranges for year 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HLS:US $37.19 USD +0.57

HLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amsurg Corp $48.09 USD +0.14
Emeritus Corp $33.84 USD -0.14
Gentiva Health Services Inc $18.28 USD +0.10
MEDNAX Inc $57.51 USD -0.44
Select Medical Holdings Corp $15.59 USD +0.03
View Industry Companies
 

Industry Analysis

HLS

Industry Average

Valuation HLS Industry Range
Price/Earnings 13.9x
Price/Sales 1.4x
Price/Book 9.1x
Price/Cash Flow 7.7x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHSOUTH CORP, please visit www.healthsouth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.